ArticleFrontiers in bioengineering and biotechnology2026
Topical application of cellulose membrane for the treatment of non-healing venous leg ulcers.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Venous leg ulcer (VLU) is a common, chronic condition that may lead to disability. Its frequency increases with age and generates high costs for healthcare systems. Bacterial cellulose is recognized as a natural wound repair material that meets the requirements of modern wound dressings, owing to its superior physicochemical characteristics and favorable biological properties. The aim of this study is to assess the effect of topical application of a cellulose membrane on the healing of chronic VLUs. Methods: Analysis included 100 patients with chronic VLUs divided into two groups of 50 patients each. Experimental group received a cellulose membrane, whereas control group received a standard antimicrobial calcium alginate dressing with silver. Planimetric measurements of the ulcer area before treatment and then every 7 days were performed, until the ulcer healed completely. The effectiveness of both treatments was compared regarding complete healing time and ulceration area reduction over time. Results: Patients in experimental group demonstrated significantly shorter complete healing time and a greater reduction in ulcer area over time in comparison to control group. However, in the control group, a temporary acceleration of healing process was observed between 5 Discussion: Our findings suggest that cellulose-based biomaterials may represent an effective and biocompatible alternative in the management of VLUs, offering improved healing outcomes and potential benefits for both patients and healthcare systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.